These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14598967)

  • 1. Characteristics associated with reported sputum culture conversion in the era of re-emergent Mycobacterium tuberculosis in the State of North Carolina, 1993-1998.
    Salihu HM; Aliyu MH; Ratard R; Pierre-Louis BJ
    Int J Tuberc Lung Dis; 2003 Nov; 7(11):1070-6. PubMed ID: 14598967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with time to sputum smear conversion in active pulmonary tuberculosis.
    Domínguez-Castellano A; Muniain MA; Rodriguez-Baño J; Garcia M; Rios MJ; Galvez J; Perez-Cano R
    Int J Tuberc Lung Dis; 2003 May; 7(5):432-8. PubMed ID: 12757043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors that effect sputum culture conversion rate in hospitalized patients with pulmonary tuberculosis who were applied directly observation therapy and non-directly observation therapy.
    Uzundağ Işeri A; Dulkar G; Selçuk Sönmez O; Yilmaz Aydin L; Yilmaz B
    Tuberk Toraks; 2010; 58(1):44-52. PubMed ID: 20517728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
    Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis.
    Wang JY; Wang JT; Tsai TH; Hsu CL; Yu CJ; Hsueh PR; Lee LN; Yang PC
    Int J Tuberc Lung Dis; 2010 Jan; 14(1):65-71. PubMed ID: 20003697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection and sputum-culture conversion in patients diagnosed with Mycobacterium tuberculosis: a population-based study.
    Aliyu MH; Salihu HM; Ratard R
    Wien Klin Wochenschr; 2003 May; 115(10):340-6. PubMed ID: 12800448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ; Wu TS; Chiang PC; Lee MH
    J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis and other clinical presentation of HIV/AIDS in patients with or without undergoing antiretroviral therapy in Kathmandu.
    Dhungana GP; Ghimire P; Sharma S; Rijal BP
    Kathmandu Univ Med J (KUMJ); 2007; 5(1):22-6. PubMed ID: 18603981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients.
    Babb C; van der Merwe L; Beyers N; Pheiffer C; Walzl G; Duncan K; van Helden P; Hoal EG
    Tuberculosis (Edinb); 2007 Jul; 87(4):295-302. PubMed ID: 17449323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of pre-treatment bacillary load on treatment outcome of pulmonary tuberculosis patients receiving DOTS under revised national tuberculosis control programme.
    Singla R; Singla N; Sarin R; Arora VK
    Indian J Chest Dis Allied Sci; 2005; 47(1):19-23. PubMed ID: 15704711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment outcome of patients with pulmonary tuberculosis before and after the induction of directly observed therapy (DOT)].
    Matsunaga K; Nagata N; Iwata Y; Kumazoe H; Komori M; Wakamatsu K; Kajiki A; Kitahara Y
    Kekkaku; 2008 Oct; 83(10):667-72. PubMed ID: 19048942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coinfection and clinical manifestations of tuberculosis in human immunodeficiency virus-infected and -uninfected adults at a teaching hospital, northwest Ethiopia.
    Kassu A; Mengistu G; Ayele B; Diro E; Mekonnen F; Ketema D; Moges F; Mesfin T; Getachew A; Ergicho B; Elias D; Aseffa A; Wondmikun Y; Ota F
    J Microbiol Immunol Infect; 2007 Apr; 40(2):116-22. PubMed ID: 17446959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation?
    Fortún J; Martín-Dávila P; Molina A; Navas E; Hermida JM; Cobo J; Gómez-Mampaso E; Moreno S
    J Antimicrob Chemother; 2007 Apr; 59(4):794-8. PubMed ID: 17392354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion rate at two-month follow-up of smear-positive tuberculosis patients in Burkina Faso.
    Dembele SM; Ouedraogo HZ; Combary A; Saleri N; Macq J; Dujardin B
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1339-44. PubMed ID: 18034956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomized controlled trial in Mwanza, Tanzania.
    Range N; Andersen AB; Magnussen P; Mugomela A; Friis H
    Trop Med Int Health; 2005 Sep; 10(9):826-32. PubMed ID: 16135188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.